Founded in 2018 at the University of Cambridge, Abselion specializes in simplifying protein research through innovative technologies. Their flagship product, Amperia, utilizes proprietary Redox Electrochemical Detection (RED) technology to provide rapid, accurate quantification of antibodies, AAVs, and other proteins directly from crude samples in as little as one minute. This benchtop instrument enhances efficiency in life sciences research and bioprocessing by delivering real-time data and automating tedious manual tasks.